These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

286 related items for PubMed ID: 16314619

  • 1. Phase III study of efaproxiral as an adjunct to whole-brain radiation therapy for brain metastases.
    Suh JH, Stea B, Nabid A, Kresl JJ, Fortin A, Mercier JP, Senzer N, Chang EL, Boyd AP, Cagnoni PJ, Shaw E.
    J Clin Oncol; 2006 Jan 01; 24(1):106-14. PubMed ID: 16314619
    [Abstract] [Full Text] [Related]

  • 2. Improved survival, quality of life, and quality-adjusted survival in breast cancer patients treated with efaproxiral (Efaproxyn) plus whole-brain radiation therapy for brain metastases.
    Scott C, Suh J, Stea B, Nabid A, Hackman J.
    Am J Clin Oncol; 2007 Dec 01; 30(6):580-7. PubMed ID: 18091051
    [Abstract] [Full Text] [Related]

  • 3. Whole-brain radiotherapy with or without efaproxiral for the treatment of brain metastases: Determinants of response and its prognostic value for subsequent survival.
    Stea B, Suh JH, Boyd AP, Cagnoni PJ, Shaw E, REACH Study Group.
    Int J Radiat Oncol Biol Phys; 2006 Mar 15; 64(4):1023-30. PubMed ID: 16446056
    [Abstract] [Full Text] [Related]

  • 4. Phase II multicenter study of induction chemotherapy followed by concurrent efaproxiral (RSR13) and thoracic radiotherapy for patients with locally advanced non-small-cell lung cancer.
    Choy H, Nabid A, Stea B, Scott C, Roa W, Kleinberg L, Ayoub J, Smith C, Souhami L, Hamburg S, Spanos W, Kreisman H, Boyd AP, Cagnoni PJ, Curran WJ.
    J Clin Oncol; 2005 Sep 01; 23(25):5918-28. PubMed ID: 16135463
    [Abstract] [Full Text] [Related]

  • 5. Efaproxiral: a radiation enhancer used in brain metastases from breast cancer.
    Charpentier MM.
    Ann Pharmacother; 2005 Dec 01; 39(12):2038-45. PubMed ID: 16249270
    [Abstract] [Full Text] [Related]

  • 6. Role of efaproxiral in metastatic brain tumors.
    Engel RH, Kaklamani VG.
    Expert Rev Anticancer Ther; 2006 Apr 01; 6(4):477-85. PubMed ID: 16613536
    [Abstract] [Full Text] [Related]

  • 7. Efaproxiral: GSJ 61, JP 4, KDD 86, RS 4, RSR 13.
    Drugs R D; 2005 Apr 01; 6(3):178-85. PubMed ID: 15869322
    [Abstract] [Full Text] [Related]

  • 8. Nonsmall cell lung cancer presenting with synchronous solitary brain metastasis.
    Hu C, Chang EL, Hassenbusch SJ, Allen PK, Woo SY, Mahajan A, Komaki R, Liao Z.
    Cancer; 2006 May 01; 106(9):1998-2004. PubMed ID: 16572401
    [Abstract] [Full Text] [Related]

  • 9. Motexafin gadolinium combined with prompt whole brain radiotherapy prolongs time to neurologic progression in non-small-cell lung cancer patients with brain metastases: results of a phase III trial.
    Mehta MP, Shapiro WR, Phan SC, Gervais R, Carrie C, Chabot P, Patchell RA, Glantz MJ, Recht L, Langer C, Sur RK, Roa WH, Mahe MA, Fortin A, Nieder C, Meyers CA, Smith JA, Miller RA, Renschler MF.
    Int J Radiat Oncol Biol Phys; 2009 Mar 15; 73(4):1069-76. PubMed ID: 18977094
    [Abstract] [Full Text] [Related]

  • 10. Survival and neurologic outcomes in a randomized trial of motexafin gadolinium and whole-brain radiation therapy in brain metastases.
    Mehta MP, Rodrigus P, Terhaard CH, Rao A, Suh J, Roa W, Souhami L, Bezjak A, Leibenhaut M, Komaki R, Schultz C, Timmerman R, Curran W, Smith J, Phan SC, Miller RA, Renschler MF.
    J Clin Oncol; 2003 Jul 01; 21(13):2529-36. PubMed ID: 12829672
    [Abstract] [Full Text] [Related]

  • 11. A randomised phase III study of palliative radiation with concomitant carboplatin for brain metastases from non-small cell carcinoma of the lung.
    Guerrieri M, Wong K, Ryan G, Millward M, Quong G, Ball DL.
    Lung Cancer; 2004 Oct 01; 46(1):107-11. PubMed ID: 15364138
    [Abstract] [Full Text] [Related]

  • 12. Primary chemotherapy for newly diagnosed nonsmall cell lung cancer patients with synchronous brain metastases compared with whole-brain radiotherapy administered first : result of a randomized pilot study.
    Lee DH, Han JY, Kim HT, Yoon SJ, Pyo HR, Cho KH, Shin SH, Yoo H, Lee SH, Lee JS.
    Cancer; 2008 Jul 01; 113(1):143-9. PubMed ID: 18459180
    [Abstract] [Full Text] [Related]

  • 13. [Sequential treatment of VmP regimen and whole brain radiotherapy for small cell lung cancer patients with brain metastases].
    Yue X, Zang QC.
    Ai Zheng; 2004 Dec 01; 23(12):1671-6. PubMed ID: 15601558
    [Abstract] [Full Text] [Related]

  • 14. RSR13 plus cranial radiation therapy in patients with brain metastases: comparison with the Radiation Therapy Oncology Group Recursive Partitioning Analysis Brain Metastases Database.
    Shaw E, Scott C, Suh J, Kadish S, Stea B, Hackman J, Pearlman A, Murray K, Gaspar L, Mehta M, Curran W, Gerber M.
    J Clin Oncol; 2003 Jun 15; 21(12):2364-71. PubMed ID: 12805339
    [Abstract] [Full Text] [Related]

  • 15. Brain metastases in breast cancer: prognostic factors and management.
    Lee SS, Ahn JH, Kim MK, Sym SJ, Gong G, Ahn SD, Kim SB, Kim WK.
    Breast Cancer Res Treat; 2008 Oct 15; 111(3):523-30. PubMed ID: 17990100
    [Abstract] [Full Text] [Related]

  • 16. Does the incidence and outcome of brain metastases in locally advanced non-small cell lung cancer justify prophylactic cranial irradiation or early detection?
    Carolan H, Sun AY, Bezjak A, Yi QL, Payne D, Kane G, Waldron J, Leighl N, Feld R, Burkes R, Keshavjee S, Shepherd F.
    Lung Cancer; 2005 Jul 15; 49(1):109-15. PubMed ID: 15949596
    [Abstract] [Full Text] [Related]

  • 17. [Survival status of stage IV non-small cell lung cancer patients after radiotherapy--a report of 287 cases].
    Cai Y, Wang WL, Xu B, Zhu GY, Zhang SW.
    Ai Zheng; 2006 Nov 15; 25(11):1419-22. PubMed ID: 17094913
    [Abstract] [Full Text] [Related]

  • 18. Prophylactic cranial irradiation in operable stage IIIA non small-cell lung cancer treated with neoadjuvant chemoradiotherapy: results from a German multicenter randomized trial.
    Pöttgen C, Eberhardt W, Grannass A, Korfee S, Stüben G, Teschler H, Stamatis G, Wagner H, Passlick B, Petersen V, Budach V, Wilhelm H, Wanke I, Hirche H, Wilke HJ, Stuschke M.
    J Clin Oncol; 2007 Nov 01; 25(31):4987-92. PubMed ID: 17971598
    [Abstract] [Full Text] [Related]

  • 19. A phase III study of conventional radiation therapy plus thalidomide versus conventional radiation therapy for multiple brain metastases (RTOG 0118).
    Knisely JP, Berkey B, Chakravarti A, Yung AW, Curran WJ, Robins HI, Movsas B, Brachman DG, Henderson RH, Mehta MP.
    Int J Radiat Oncol Biol Phys; 2008 May 01; 71(1):79-86. PubMed ID: 18164847
    [Abstract] [Full Text] [Related]

  • 20. Up-front chemotherapy and radiation treatment in newly diagnosed nonsmall cell lung cancer with brain metastases: survey by Outcome Research Network for Evaluation of Treatment Results in Oncology.
    Moscetti L, Nelli F, Felici A, Rinaldi M, De Santis S, D'Auria G, Mansueto G, Tonini G, Sperduti I, Pollera FC.
    Cancer; 2007 Jan 15; 109(2):274-81. PubMed ID: 17154161
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 15.